9.11
5.93%
0.51
Monte Rosa Therapeutics Inc Stock (GLUE) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
1.064
|
- | - | - | - |
Operating Expenses
|
3.29%
36.01
|
34.86 | 36.97 | 37.22 | 34.26 |
Benefits Costs and Expenses |
32.95
|
- | - | - | - |
Costs And Expenses |
32.95
|
- | - | - | - |
Operating Income/Loss |
0.24%
-34.95
|
-34.86 | -36.97 | -37.22 | -34.26 |
Nonoperating Income/Loss |
92.70%
3.062
|
1.589 | 2.254 | 2.233 | 2.221 |
Income/Loss From Continuing Operations Before Tax |
4.17%
-31.89
|
-33.27 | -34.71 | -34.99 | -32.04 |
Income Tax Expense/Benefit |
477.27%
0.083
|
-0.022 | 0.17 | 0.19 | - |
Income/Loss From Continuing Operations After Tax |
3.86%
-31.97
|
-33.25 | -34.88 | -35.18 | -32.04 |
Net Income/Loss
|
3.86%
-31.97
|
-33.25 | -34.88 | -35.18 | -32.04 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,128%
60.16
|
1.8638 | 49.81 | 49.43 | 49.35 |
Diluted Average Shares |
3,128%
60.16
|
1.8638 | 49.81 | 49.43 | 49.35 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):